Ivena Armand Email & Phone Number

Beverly Hills, CA, US

Bedford, MA, US

Cambridge, MA, US

Participate in the roll out of the newly launched first-in-kind anti-VEGF Biosimilar in Ophthalmology, Byooviz, providing patients with additional treatment options for those suffering from neovascular WET age-related macular degeneration, macular edema following retinal vein occlusion, and myopic choroidal neovascularization.

Osaka, Japan, JP

• Ranked 6th nationally for overall growth in 2 out of 3 products Q1 (January 2022 - April 2022);
• 120% to quota on two out of three products Q3 (September 2021 - December 2021);
• Won "Highest Contributor Award" - IC Kicker Contest Q3 (September 2021- December 2021);
• Increased sales volume by 95% and 80% respectively for two products in the portfolio within the first year of employment;
• Successfully converted 6 surgical accounts for post-op treatments in less than 1 year;
• Successfully launched rare disease drug, Verkazia, June 2021

Managed the pipeline of prospective listing opportunities as well as current listings by implementing strategic tactics to stay engaged with clients. Communicated with high-level executives, business managers, and attorneys to successfully close over $15M in sales volume. Performed market research to provide an in-depth analysis to maximize client ROI.

Oversaw the day-to-day operations of a 56-person luxury real estate team working cross-functionally with the President, Administrative Director, Transaction Coordinators, Marketing Director, Creative Director, and Buyers Agents. Prepared market analysis’ and conducted client updates to communicate market activity. Spearheaded weekly agent trainings for.